APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical Process Development Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biopharmaceutical Process Development Services Market Analysis and Forecast 2026-2032

17 January 2026192 pages

Choose your research edition.

Industry ResearchBiopharmaceutical Process Development Services Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical Process Development Services Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical Process Development Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical Process Development Services Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical Process Development Services Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Biopharmaceutical Process Development Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biopharmaceutical Process Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biopharmaceutical Process Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biopharmaceutical Process Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biopharmaceutical Process Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biopharmaceutical Process Development Services include Merck Millipore, Cytiva, Coriolis Pharma, Lonza, Premas Biotech, Kemwell Biopharma, Avantor, Pace Life Sciences and KBI Biopharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biopharmaceutical Process Development Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biopharmaceutical Process Development Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Biopharmaceutical Process Development Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biopharmaceutical Process Development Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biopharmaceutical Process Development Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biopharmaceutical Process Development Services revenue, projected growth trends, production technology, application and end-user industry.

Biopharmaceutical Process Development Services Segment by Company

Merck Millipore

Cytiva

Coriolis Pharma

Lonza

Premas Biotech

Kemwell Biopharma

Avantor

Pace Life Sciences

KBI Biopharma

Rommelag

FyoniBio

Rentschler Biopharma SE

BioPharma Services

GenIbet

Biopharmaceutical Process Development Services Segment by Type

Cell Culture

Upstream Process Development

Downstream Process Development

Biopharmaceutical Process Development Services Segment by Application

Small and Medium Enterprises

Large Enterprises

Biopharmaceutical Process Development Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Process Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Process Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Process Development Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biopharmaceutical Process Development Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biopharmaceutical Process Development Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceutical Process Development Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biopharmaceutical Process Development Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cell Culture Major Player Table 3. Upstream Process Development Major Player Table 4. Downstream Process Development Major Player Table 5. Global Biopharmaceutical Process Development Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Small and Medium Enterprises Major Player Table 7. Large Enterprises Major Player Table 8. Biopharmaceutical Process Development Services Industry Trends Table 9. Biopharmaceutical Process Development Services Industry Drivers Table 10. Biopharmaceutical Process Development Services Industry Opportunities and Challenges Table 11. Biopharmaceutical Process Development Services Industry Restraints Table 12. Global Biopharmaceutical Process Development Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Biopharmaceutical Process Development Services Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Biopharmaceutical Process Development Services Market Share by Region (2021-2026) Table 15. Global Biopharmaceutical Process Development Services Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Biopharmaceutical Process Development Services Market Share by Region (2027-2032) Table 17. Global Biopharmaceutical Process Development Services Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Biopharmaceutical Process Development Services Revenue Market Share by Players (2021-2026) Table 19. Global Biopharmaceutical Process Development Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Biopharmaceutical Process Development Services Key Players Headquarters & Area Served Table 21. Global Biopharmaceutical Process Development Services Players, Product Type & Application Table 22. Global Biopharmaceutical Process Development Services Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Biopharmaceutical Process Development Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Biopharmaceutical Process Development Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biopharmaceutical Process Development Services Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Biopharmaceutical Process Development Services Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Biopharmaceutical Process Development Services Revenue Market Share by Type (2021-2026) Table 29. Global Biopharmaceutical Process Development Services Revenue Market Share by Type (2027-2032) Table 30. Global Biopharmaceutical Process Development Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biopharmaceutical Process Development Services Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Biopharmaceutical Process Development Services Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Biopharmaceutical Process Development Services Revenue Market Share by Application (2021-2026) Table 34. Global Biopharmaceutical Process Development Services Revenue Market Share by Application (2027-2032) Table 35. Merck Millipore Company Information Table 36. Merck Millipore Business Overview Table 37. Merck Millipore Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Merck Millipore Biopharmaceutical Process Development Services Product Portfolio Table 39. Merck Millipore Recent Development Table 40. Cytiva Company Information Table 41. Cytiva Business Overview Table 42. Cytiva Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Cytiva Biopharmaceutical Process Development Services Product Portfolio Table 44. Cytiva Recent Development Table 45. Coriolis Pharma Company Information Table 46. Coriolis Pharma Business Overview Table 47. Coriolis Pharma Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Coriolis Pharma Biopharmaceutical Process Development Services Product Portfolio Table 49. Coriolis Pharma Recent Development Table 50. Lonza Company Information Table 51. Lonza Business Overview Table 52. Lonza Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Lonza Biopharmaceutical Process Development Services Product Portfolio Table 54. Lonza Recent Development Table 55. Premas Biotech Company Information Table 56. Premas Biotech Business Overview Table 57. Premas Biotech Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Premas Biotech Biopharmaceutical Process Development Services Product Portfolio Table 59. Premas Biotech Recent Development Table 60. Kemwell Biopharma Company Information Table 61. Kemwell Biopharma Business Overview Table 62. Kemwell Biopharma Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Kemwell Biopharma Biopharmaceutical Process Development Services Product Portfolio Table 64. Kemwell Biopharma Recent Development Table 65. Avantor Company Information Table 66. Avantor Business Overview Table 67. Avantor Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Avantor Biopharmaceutical Process Development Services Product Portfolio Table 69. Avantor Recent Development Table 70. Pace Life Sciences Company Information Table 71. Pace Life Sciences Business Overview Table 72. Pace Life Sciences Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Pace Life Sciences Biopharmaceutical Process Development Services Product Portfolio Table 74. Pace Life Sciences Recent Development Table 75. KBI Biopharma Company Information Table 76. KBI Biopharma Business Overview Table 77. KBI Biopharma Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. KBI Biopharma Biopharmaceutical Process Development Services Product Portfolio Table 79. KBI Biopharma Recent Development Table 80. Rommelag Company Information Table 81. Rommelag Business Overview Table 82. Rommelag Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Rommelag Biopharmaceutical Process Development Services Product Portfolio Table 84. Rommelag Recent Development Table 85. FyoniBio Company Information Table 86. FyoniBio Business Overview Table 87. FyoniBio Biopharmaceutical Process Development Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. FyoniBio Biopharmaceutical Process Development Services Product Portfolio Table 89. FyoniBio Recent Development Table 90. Rentschler Biopharma SE Company Information Table 91. Rentschler Biopharma SE Business Overview Table 92. Rentschler Biopharma SE Biopharmaceutical Process Development Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Rentschler Biopharma SE Biopharmaceutical Process Development Services Product Portfolio Table 94. Rentschler Biopharma SE Recent Development Table 95. BioPharma Services Company Information Table 96. BioPharma Services Business Overview Table 97. BioPharma Services Biopharmaceutical Process Development Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. BioPharma Services Biopharmaceutical Process Development Services Product Portfolio Table 99. BioPharma Services Recent Development Table 100. GenIbet Company Information Table 101. GenIbet Business Overview Table 102. GenIbet Biopharmaceutical Process Development Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. GenIbet Biopharmaceutical Process Development Services Product Portfolio Table 104. GenIbet Recent Development Table 105. North America Biopharmaceutical Process Development Services Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Biopharmaceutical Process Development Services Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Biopharmaceutical Process Development Services Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Biopharmaceutical Process Development Services Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Biopharmaceutical Process Development Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Biopharmaceutical Process Development Services Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Biopharmaceutical Process Development Services Revenue by Country (US$ Million) & (2027-2032) Table 112. Europe Biopharmaceutical Process Development Services Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Biopharmaceutical Process Development Services Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Biopharmaceutical Process Development Services Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Biopharmaceutical Process Development Services Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Biopharmaceutical Process Development Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Biopharmaceutical Process Development Services Revenue by Country (2021-2026) & (US$ Million) Table 118. Europe Biopharmaceutical Process Development Services Revenue by Country (US$ Million) & (2027-2032) Table 119. China Biopharmaceutical Process Development Services Revenue by Type (2021-2026) & (US$ Million) Table 120. China Biopharmaceutical Process Development Services Revenue by Type (2027-2032) & (US$ Million) Table 121. China Biopharmaceutical Process Development Services Revenue by Application (2021-2026) & (US$ Million) Table 122. China Biopharmaceutical Process Development Services Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Biopharmaceutical Process Development Services Revenue by Type (2021-2026) & (US$ Million) Table 124. Asia Biopharmaceutical Process Development Services Revenue by Type (2027-2032) & (US$ Million) Table 125. Asia Biopharmaceutical Process Development Services Revenue by Application (2021-2026) & (US$ Million) Table 126. Asia Biopharmaceutical Process Development Services Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Biopharmaceutical Process Development Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Biopharmaceutical Process Development Services Revenue by Region (US$ Million) & (2021-2026) Table 129. Asia Biopharmaceutical Process Development Services Revenue by Region (US$ Million) & (2027-2032) Table 130. SAMEA Biopharmaceutical Process Development Services Revenue by Type (2021-2026) & (US$ Million) Table 131. SAMEA Biopharmaceutical Process Development Services Revenue by Type (2027-2032) & (US$ Million) Table 132. SAMEA Biopharmaceutical Process Development Services Revenue by Application (2021-2026) & (US$ Million) Table 133. SAMEA Biopharmaceutical Process Development Services Revenue by Application (2027-2032) & (US$ Million) Table 134. SAMEA Biopharmaceutical Process Development Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. SAMEA Biopharmaceutical Process Development Services Revenue by Country (2021-2026) & (US$ Million) Table 136. SAMEA Biopharmaceutical Process Development Services Revenue by Country (US$ Million) & (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Biopharmaceutical Process Development Services Image Figure 2. Global Biopharmaceutical Process Development Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biopharmaceutical Process Development Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cell Culture Image Figure 5. Upstream Process Development Image Figure 6. Downstream Process Development Image Figure 7. Global Biopharmaceutical Process Development Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Biopharmaceutical Process Development Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Small and Medium Enterprises Image Figure 10. Large Enterprises Image Figure 11. Global Biopharmaceutical Process Development Services Market Size (US$ Million) & (2021-2032) Figure 12. Global Biopharmaceutical Process Development Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Biopharmaceutical Process Development Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Biopharmaceutical Process Development Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Biopharmaceutical Process Development Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Biopharmaceutical Process Development Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Biopharmaceutical Process Development Services Revenue Market Share by Type (2021-2032) Figure 19. Global Biopharmaceutical Process Development Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biopharmaceutical Process Development Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Biopharmaceutical Process Development Services Revenue Market Share by Application (2021-2032) Figure 22. North America Biopharmaceutical Process Development Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Biopharmaceutical Process Development Services Revenue Share by Type (2021-2032) Figure 24. North America Biopharmaceutical Process Development Services Revenue Share by Application (2021-2032) Figure 25. North America Biopharmaceutical Process Development Services Revenue Share by Country (2021-2032) Figure 26. United States Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Biopharmaceutical Process Development Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Biopharmaceutical Process Development Services Revenue Share by Type (2021-2032) Figure 31. Europe Biopharmaceutical Process Development Services Revenue Share by Application (2021-2032) Figure 32. Europe Biopharmaceutical Process Development Services Revenue Share by Country (2021-2032) Figure 33. Germany Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Biopharmaceutical Process Development Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Biopharmaceutical Process Development Services Revenue Share by Type (2021-2032) Figure 43. China Biopharmaceutical Process Development Services Revenue Share by Application (2021-2032) Figure 44. Asia Biopharmaceutical Process Development Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Biopharmaceutical Process Development Services Revenue Share by Type (2021-2032) Figure 46. Asia Biopharmaceutical Process Development Services Revenue Share by Application (2021-2032) Figure 47. Asia Biopharmaceutical Process Development Services Revenue Share by Region (2021-2032) Figure 48. Japan Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Biopharmaceutical Process Development Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Biopharmaceutical Process Development Services Revenue Share by Type (2021-2032) Figure 56. SAMEA Biopharmaceutical Process Development Services Revenue Share by Application (2021-2032) Figure 57. SAMEA Biopharmaceutical Process Development Services Revenue Share by Country (2021-2032) Figure 58. Brazil Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Biopharmaceutical Process Development Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cell Culture
  • Upstream Process Development
  • Downstream Process Development
Applications
  • Small and Medium Enterprises
  • Large Enterprises
Companies covered
  • Merck Millipore
  • Cytiva
  • Coriolis Pharma
  • Lonza
  • Premas Biotech
  • Kemwell Biopharma
  • Avantor
  • Pace Life Sciences
  • KBI Biopharma
  • Rommelag
  • FyoniBio
  • Rentschler Biopharma SE
  • BioPharma Services
  • GenIbet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biopharmaceutical Process Development Services Market by Type
  3. 1.2.1 Global Biopharmaceutical Process Development Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cell Culture
  5. 1.2.3 Upstream Process Development
  6. 1.2.4 Downstream Process Development
  7. 1.3 Biopharmaceutical Process Development Services Market by Application
  8. 1.3.1 Global Biopharmaceutical Process Development Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Small and Medium Enterprises
  10. 1.3.3 Large Enterprises
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Biopharmaceutical Process Development Services Market Dynamics
  1. 2.1 Biopharmaceutical Process Development Services Industry Trends
  2. 2.2 Biopharmaceutical Process Development Services Industry Drivers
  3. 2.3 Biopharmaceutical Process Development Services Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical Process Development Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biopharmaceutical Process Development Services Market Perspective (2021-2032)
  2. 3.2 Global Biopharmaceutical Process Development Services Growth Trends by Region
  3. 3.2.1 Global Biopharmaceutical Process Development Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biopharmaceutical Process Development Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Biopharmaceutical Process Development Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biopharmaceutical Process Development Services Revenue by Players
  2. 4.1.1 Global Biopharmaceutical Process Development Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Biopharmaceutical Process Development Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biopharmaceutical Process Development Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biopharmaceutical Process Development Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biopharmaceutical Process Development Services Key Players Headquarters & Area Served
  7. 4.4 Global Biopharmaceutical Process Development Services Players, Product Type & Application
  8. 4.5 Global Biopharmaceutical Process Development Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biopharmaceutical Process Development Services Market CR5 and HHI
  11. 4.6.3 2025 Biopharmaceutical Process Development Services Tier 1, Tier 2, and Tier 3
5 Biopharmaceutical Process Development Services Market Size by Type
  1. 5.1 Global Biopharmaceutical Process Development Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biopharmaceutical Process Development Services Revenue by Type (2021-2032)
  3. 5.3 Global Biopharmaceutical Process Development Services Revenue Market Share by Type (2021-2032)
6 Biopharmaceutical Process Development Services Market Size by Application
  1. 6.1 Global Biopharmaceutical Process Development Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biopharmaceutical Process Development Services Revenue by Application (2021-2032)
  3. 6.3 Global Biopharmaceutical Process Development Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck Millipore
  2. 7.1.1 Merck Millipore Company Information
  3. 7.1.2 Merck Millipore Business Overview
  4. 7.1.3 Merck Millipore Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck Millipore Biopharmaceutical Process Development Services Product Portfolio
  6. 7.1.5 Merck Millipore Recent Developments
  7. 7.2 Cytiva
  8. 7.2.1 Cytiva Company Information
  9. 7.2.2 Cytiva Business Overview
  10. 7.2.3 Cytiva Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cytiva Biopharmaceutical Process Development Services Product Portfolio
  12. 7.2.5 Cytiva Recent Developments
  13. 7.3 Coriolis Pharma
  14. 7.3.1 Coriolis Pharma Company Information
  15. 7.3.2 Coriolis Pharma Business Overview
  16. 7.3.3 Coriolis Pharma Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Coriolis Pharma Biopharmaceutical Process Development Services Product Portfolio
  18. 7.3.5 Coriolis Pharma Recent Developments
  19. 7.4 Lonza
  20. 7.4.1 Lonza Company Information
  21. 7.4.2 Lonza Business Overview
  22. 7.4.3 Lonza Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Lonza Biopharmaceutical Process Development Services Product Portfolio
  24. 7.4.5 Lonza Recent Developments
  25. 7.5 Premas Biotech
  26. 7.5.1 Premas Biotech Company Information
  27. 7.5.2 Premas Biotech Business Overview
  28. 7.5.3 Premas Biotech Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Premas Biotech Biopharmaceutical Process Development Services Product Portfolio
  30. 7.5.5 Premas Biotech Recent Developments
  31. 7.6 Kemwell Biopharma
  32. 7.6.1 Kemwell Biopharma Company Information
  33. 7.6.2 Kemwell Biopharma Business Overview
  34. 7.6.3 Kemwell Biopharma Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Kemwell Biopharma Biopharmaceutical Process Development Services Product Portfolio
  36. 7.6.5 Kemwell Biopharma Recent Developments
  37. 7.7 Avantor
  38. 7.7.1 Avantor Company Information
  39. 7.7.2 Avantor Business Overview
  40. 7.7.3 Avantor Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Avantor Biopharmaceutical Process Development Services Product Portfolio
  42. 7.7.5 Avantor Recent Developments
  43. 7.8 Pace Life Sciences
  44. 7.8.1 Pace Life Sciences Company Information
  45. 7.8.2 Pace Life Sciences Business Overview
  46. 7.8.3 Pace Life Sciences Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Pace Life Sciences Biopharmaceutical Process Development Services Product Portfolio
  48. 7.8.5 Pace Life Sciences Recent Developments
  49. 7.9 KBI Biopharma
  50. 7.9.1 KBI Biopharma Company Information
  51. 7.9.2 KBI Biopharma Business Overview
  52. 7.9.3 KBI Biopharma Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 KBI Biopharma Biopharmaceutical Process Development Services Product Portfolio
  54. 7.9.5 KBI Biopharma Recent Developments
  55. 7.10 Rommelag
  56. 7.10.1 Rommelag Company Information
  57. 7.10.2 Rommelag Business Overview
  58. 7.10.3 Rommelag Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Rommelag Biopharmaceutical Process Development Services Product Portfolio
  60. 7.10.5 Rommelag Recent Developments
  61. 7.11 FyoniBio
  62. 7.11.1 FyoniBio Company Information
  63. 7.11.2 FyoniBio Business Overview
  64. 7.11.3 FyoniBio Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 FyoniBio Biopharmaceutical Process Development Services Product Portfolio
  66. 7.11.5 FyoniBio Recent Developments
  67. 7.12 Rentschler Biopharma SE
  68. 7.12.1 Rentschler Biopharma SE Company Information
  69. 7.12.2 Rentschler Biopharma SE Business Overview
  70. 7.12.3 Rentschler Biopharma SE Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Rentschler Biopharma SE Biopharmaceutical Process Development Services Product Portfolio
  72. 7.12.5 Rentschler Biopharma SE Recent Developments
  73. 7.13 BioPharma Services
  74. 7.13.1 BioPharma Services Company Information
  75. 7.13.2 BioPharma Services Business Overview
  76. 7.13.3 BioPharma Services Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 BioPharma Services Biopharmaceutical Process Development Services Product Portfolio
  78. 7.13.5 BioPharma Services Recent Developments
  79. 7.14 GenIbet
  80. 7.14.1 GenIbet Company Information
  81. 7.14.2 GenIbet Business Overview
  82. 7.14.3 GenIbet Biopharmaceutical Process Development Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 GenIbet Biopharmaceutical Process Development Services Product Portfolio
  84. 7.14.5 GenIbet Recent Developments
8 North America
  1. 8.1 North America Biopharmaceutical Process Development Services Revenue (2021-2032)
  2. 8.2 North America Biopharmaceutical Process Development Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Biopharmaceutical Process Development Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Biopharmaceutical Process Development Services Revenue by Type (2027-2032)
  5. 8.3 North America Biopharmaceutical Process Development Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Biopharmaceutical Process Development Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Biopharmaceutical Process Development Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Biopharmaceutical Process Development Services Revenue by Application (2027-2032)
  9. 8.5 North America Biopharmaceutical Process Development Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Biopharmaceutical Process Development Services Revenue by Country
  11. 8.6.1 North America Biopharmaceutical Process Development Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biopharmaceutical Process Development Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Biopharmaceutical Process Development Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biopharmaceutical Process Development Services Revenue (2021-2032)
  2. 9.2 Europe Biopharmaceutical Process Development Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biopharmaceutical Process Development Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biopharmaceutical Process Development Services Revenue by Type (2027-2032)
  5. 9.3 Europe Biopharmaceutical Process Development Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biopharmaceutical Process Development Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biopharmaceutical Process Development Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biopharmaceutical Process Development Services Revenue by Application (2027-2032)
  9. 9.5 Europe Biopharmaceutical Process Development Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biopharmaceutical Process Development Services Revenue by Country
  11. 9.6.1 Europe Biopharmaceutical Process Development Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biopharmaceutical Process Development Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biopharmaceutical Process Development Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biopharmaceutical Process Development Services Revenue (2021-2032)
  2. 10.2 China Biopharmaceutical Process Development Services Revenue by Type (2021-2032)
  3. 10.2.1 China Biopharmaceutical Process Development Services Revenue by Type (2021-2026)
  4. 10.2.2 China Biopharmaceutical Process Development Services Revenue by Type (2027-2032)
  5. 10.3 China Biopharmaceutical Process Development Services Revenue Share by Type (2021-2032)
  6. 10.4 China Biopharmaceutical Process Development Services Revenue by Application (2021-2032)
  7. 10.4.1 China Biopharmaceutical Process Development Services Revenue by Application (2021-2026)
  8. 10.4.2 China Biopharmaceutical Process Development Services Revenue by Application (2027-2032)
  9. 10.5 China Biopharmaceutical Process Development Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biopharmaceutical Process Development Services Revenue (2021-2032)
  2. 11.2 Asia Biopharmaceutical Process Development Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biopharmaceutical Process Development Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biopharmaceutical Process Development Services Revenue by Type (2027-2032)
  5. 11.3 Asia Biopharmaceutical Process Development Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biopharmaceutical Process Development Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biopharmaceutical Process Development Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biopharmaceutical Process Development Services Revenue by Application (2027-2032)
  9. 11.5 Asia Biopharmaceutical Process Development Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biopharmaceutical Process Development Services Revenue by Country
  11. 11.6.1 Asia Biopharmaceutical Process Development Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biopharmaceutical Process Development Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biopharmaceutical Process Development Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biopharmaceutical Process Development Services Revenue (2021-2032)
  2. 12.2 SAMEA Biopharmaceutical Process Development Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biopharmaceutical Process Development Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biopharmaceutical Process Development Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biopharmaceutical Process Development Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biopharmaceutical Process Development Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biopharmaceutical Process Development Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biopharmaceutical Process Development Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biopharmaceutical Process Development Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biopharmaceutical Process Development Services Revenue by Country
  11. 12.6.1 SAMEA Biopharmaceutical Process Development Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biopharmaceutical Process Development Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biopharmaceutical Process Development Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst